Market closed

Apyx Medical/$APYX

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Apyx Medical

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.

Ticker

$APYX
Sector
Health Care
Trading on
NASDAQ

Industry

Health Care Equipment & Supplies
Headquarters
Clearwater, United States

Employees

252
Website
apyxmedical.com

Apyx Medical Metrics

BasicAdvanced
$56M
-
-$0.82
1.21
-

$56M

1.21

$2.80

$0.97

70K

5.459

4.296

343.815

346.941

-3.97%

-22.18%

-127.39%

1.063

4.68

4.68

-2.885

-3.49%

87.49%

4.00%

24.21%

What the Analysts think about Apyx Medical

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Apyx Medical stock.

Apyx Medical Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Apyx Medical Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-

Apyx Medical News

AllArticlesVideos
Apyx Medical Corporation Submits 510(k) Premarket Notification to the U.S. Food and Drug Administration for the AYON Body Contouring System™

Apyx Medical Corporation Submits 510(k) Premarket Notification to the U.S. Food and Drug Administration for the AYON Body Contouring System™

GlobeNewsWire·1 week ago
Apyx Medical Corporation to Attend 15th Annual Craig-Hallum Alpha Select Conference

Apyx Medical Corporation to Attend 15th Annual Craig-Hallum Alpha Select Conference

GlobeNewsWire·2 months ago
Apyx Medical Corporation (APYX) Q3 2024 Earnings Call Transcript

Apyx Medical Corporation (APYX) Q3 2024 Earnings Call Transcript

Seeking Alpha·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $APYX

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Apyx Medical stock?

Apyx Medical (APYX) has a market cap of $56M as of January 15, 2025.

What is the P/E ratio for Apyx Medical stock?

The price to earnings (P/E) ratio for Apyx Medical (APYX) stock is 0 as of January 15, 2025.

Does Apyx Medical stock pay dividends?

No, Apyx Medical (APYX) stock does not pay dividends to its shareholders as of January 15, 2025.

When is the next Apyx Medical dividend payment date?

Apyx Medical (APYX) stock does not pay dividends to its shareholders.

What is the beta indicator for Apyx Medical?

Apyx Medical (APYX) has a beta rating of 1.21. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.